Price Alert

Anixa Biosciences Inc. (ANIX)

NASDAQ: ANIX · Real-Time Price · USD

2.97

0.00 (0.00%)

At close: Aug 15, 2025, 3:59 PM

2.97

0.00%

After-hours: Aug 15, 2025, 07:56 PM EDT

Anixa Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is November - October.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Apr 30, 2025	Jan 31, 2025	Oct 31, 2024	Jul 31, 2024	Apr 30, 2024	Jan 31, 2024	Oct 31, 2023	Jul 31, 2023	Apr 30, 2023	Jan 31, 2023	Oct 31, 2022	Jul 31, 2022	Apr 30, 2022	Jan 31, 2022	Oct 31, 2021	Jul 31, 2021	Apr 30, 2021	Jan 31, 2021
Cash & Equivalents	1.91M	1.05M	1.27M	1.23M	995K	998K	915K	3.2M	5.62M	9.79M	12.36M	24.25M	27.73M	29.78M	29.13M	27.22M	27.7M	11.98M
Short-Term Investments	13.69M	16.2M	18.65M	19.52M	22.24M	22.8M	22.93M	22.34M	21.36M	17.91M	17.33M	7.41M	4.5M	4.75M	6.6M	9.4M	10.4M	2M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-178K	-189K	-201K	-212K	-223K	-234K	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	173K	410K	218K	391K	270K	334K	256K	147K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-46K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.17M	1.43M	1.26M	1.51M	757K	1.03M	1.24M	532K	178K	256K	46K	n/a	332K	464K	275.56K	430.01K	369.21K	581.32K
Total Current Assets	16.77M	18.69M	21.36M	22.67M	24.21M	25.22M	25.36M	26.4M	27.41M	28.11M	30.2M	32.34M	32.56M	34.99M	36M	37.05M	38.47M	14.56M
Property-Plant & Equipment	211K	220K	229K	238K	141K	153K	166K	178K	189K	201K	212K	223K	234K	244K	253.96K	10.41K	25.57K	40.21K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	211K	220K	229K	238K	141K	153K	166K	178K	189K	201K	212K	223K	234K	244K	253.96K	10.41K	25.57K	40.21K
Total Assets	16.98M	18.91M	21.59M	22.91M	24.36M	25.37M	25.52M	26.58M	27.6M	28.31M	30.41M	32.56M	32.8M	35.24M	36.26M	37.06M	38.5M	14.6M
Account Payables	284K	600K	525K	302K	215K	364K	206K	94K	195K	110K	265K	227K	93K	504K	136K	207.73K	438.01K	511.82K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	56K	54K	52K	51K	49K	47K	46K	n/a	39K	41K	39.4K	10.57K	25.96K	40.84K
Other Current Liabilities	n/a	1.36M	n/a	754K	636K	636K	604K	684K	-45K	567K	536K	577K	541K	598K	564.18K	586.78K	642.29K	703.84K
Total Current Liabilities	1.89M	2M	2.5M	2M	1.68M	1.66M	2.03M	1.86M	1.54M	1.23M	2.04M	1.47M	1.19M	1.79M	1.27M	1.21M	1.44M	1.53M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	82.00	n/a	n/a	n/a
Total Long-Term Liabilities	184K	194K	203K	213K	93K	108K	123K	136K	149K	162K	175K	187K	202K	209K	220.08K	218.3K	463.98K	552.65K
Total Liabilities	2.07M	2.19M	2.7M	2.22M	1.77M	1.77M	2.15M	1.99M	1.69M	1.39M	2.21M	1.66M	1.39M	2M	1.49M	1.21M	1.44M	1.53M
Total Debt	221K	230K	232K	237K	149K	162K	175K	187K	198K	209K	221K	231K	241K	250K	259.48K	10.57K	25.96K	40.84K
Common Stock	322K	322K	322K	321K	320K	318K	311K	310K	310K	309K	309K	307K	302K	301K	300.51K	299.5K	314.5K	261.79K
Retained Earnings	-246.72M	-243.93M	-240.75M	-237.87M	-234.59M	-231.45M	-228.2M	-225.51M	-223M	-220.71M	-218.38M	-214.91M	-212.16M	-208.62M	-204.79M	-200.78M	-196.44M	-194.04M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders Equity	16.07M	17.85M	20M	21.77M	23.62M	24.61M	24.34M	25.52M	26.81M	27.79M	29.05M	31.7M	32.17M	33.96M	35.44M	36.47M	37.61M	13.6M
Total Investments	13.69M	16.2M	18.65M	19.52M	22.24M	22.8M	22.93M	22.34M	21.36M	17.91M	17.33M	7.41M	4.5M	4.75M	6.6M	9.4M	10.4M	2M